Nemaura Medical Inc. is a medical technology company specializing in the development and commercialization of non-invasive, wearable diagnostic devices aimed at chronic disease management. The company is best known for SugarBEAT®, a wearable continuous glucose monitoring system designed to provide real-time glucose trend data for individuals with Type I and Type II diabetes, as well as those with pre-diabetic conditions. SugarBEAT® operates via a disposable skin patch connected to a rechargeable transmitter, delivering glucose readings to a mobile application at five-minute intervals for up to 24 hours at a time. Nemaura’s portfolio extends beyond diabetes care, encompassing digital health solutions for weight management, Type 2 diabetes prevention, and continuous lactate and temperature monitoring for medical and wellness applications. By offering non-invasive alternatives to traditional diagnostic methods, Nemaura Medical aims to empower patients and healthcare providers with affordable tools for better disease monitoring and personalized health management, with a particular focus on enhancing the quality of life for those managing chronic conditions.